Clinical Trials Logo

Clinical Trial Summary

Main research purposes of this research is to compare the therapeutic effect and safety of the superior levator muscle shortening combined with the tarsus resection and the traditional frontal muscle flap in the correction of severe ptosis.

Aside of above we also tend to explore the dose-effect relationship between the amount of levator muscle shortened/ tarsus resection and postoperative ptosis correction amount.So as to develop a more critical and specific guidelines for clinical treatment of ptosis.

So during the research we will recruiting patients with severe ptosis and randomly divide them into levator muscle and tarsus group and frontal muscle flap group, and follow up those patient 6 months post operation so as to evaluate the amount of correction and the side-symptoms.


Clinical Trial Description

The ptosis is divided into light, medium and severe according to the difference in muscle strength of the upper levator muscle. According to the previous diagnosis and treatment criteria, for the mild and moderate ptosis, it is recommended to use the method of shortening or partial resection of the levator muscle. For severe patients, because the strength of the upper levator muscles are extremely weak, the function of the upper eye lid can only be reconstructed through the strength of the frontal muscles. So it is recommended to use the frontal muscle flap surgery for correct ptosis. However, compared with the levator levator shortening, the shortcoming of the frontal muscle suspension is to change the nature anatomical relationship of the upper eyelid, resulting in unnatural eye lid lines, obvious frontal lines, easy recurrence and other shortcomings. In the case, this therapy turns out not to be very satisfied.

Based on years of clinical experience in treating ptosis, our research team have tried to use the levator muscle shortening combined with the tarsus resection method for more than 10 years. We have successfully cured more than 1000 patients with severe ptosis and obtained good therapeutic effects. The results are summarized and the sequence is published in several international journals and is recognized by domestic and foreign counterparts. However, for the new procedure of levator muscle shortening combined with tarsus resection, there is currently no comparative study with traditional therapy, and it is impossible to objectively evaluate its efficacy. Secondly, how to improve the long-term effect of levator muscle shortening combined with tarsus resection, whether the eyelid morphology is satisfactory, and the recurrence rate has not been reported. In addition, because the tarsus plays an important role in the shape and function of the eye, including maintaining the function of the tarsus and keeping the cornea moist, etc., the effect of partial removal of the tarsus on the original tarsus function is also worthy of further investigation.

Based on the original clinical results, the project team designed a randomized controlled single-blind study to compare the efficacy and safety of the levator muscle shortening combined with the tarsal resection and the traditional frontal muscle flap in the correction of severe ptosis. At the same time, to explore the dose-effect relationship between the shortening of the levator muscle and the amount of tarsal resection and the amount of correction of the ptosis after operation, the surgical design is more precise and personalized, which provides a scientific basis for further development of clinical diagnosis and treatment guidelines. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03916107
Study type Interventional
Source Shanghai Jiao Tong University School of Medicine
Contact
Status Enrolling by invitation
Phase N/A
Start date January 1, 2018
Completion date December 31, 2020

See also
  Status Clinical Trial Phase
Completed NCT04585217 - A Comparison of the Effect of Suture Material on Blepharoplasty Incision N/A
Recruiting NCT05480098 - Brimonidine for Intraoperative Hemostasis Phase 4
Recruiting NCT05890027 - Phenylephrine Versus Eyelid Taping for Muller's Muscle-Conjunctival Resection (MMCR) Evaluation Phase 4
Completed NCT06047418 - Blepharoptosis in Indonesia: A 5-Year Multicenter Study on Characteristics and Surgical Evaluation
Completed NCT04831047 - The Effect of Upneeq (Oxymetazoline Hydrochloride 0.1%) on Eyelid Position, Eye Redness, and Eye Appearance Phase 4
Active, not recruiting NCT04678115 - Clinical Trial Comparing Two Non-Surgical Treatments for Severe Blepharoptosis N/A
Not yet recruiting NCT04235803 - Telemedicine Follow-up for Routine, Low-Risk Oculoplastic Surgery N/A
Completed NCT05770973 - Effect of Eyelid Patching After Ptosis Surgery N/A
Completed NCT00753831 - Efficacy of Aurosling in Frontalis Sling Suspension Surgery Phase 4
Completed NCT04291625 - Evaluation of Intraoperative Lagophthalmos Formula N/A
Completed NCT03818204 - Clinical Trial to Improve the Magnetic Levator Prosthesis N/A
Recruiting NCT05750251 - Effect of Upper Eyelid Surgeries on Corneal Characteristics
Not yet recruiting NCT03392272 - Modified Müller's Muscle-conjunctival Resection Internal Ptosis Repair Using Fibrin Glue N/A
Recruiting NCT01616108 - Bupivacaine Injection of Eye Muscles to Treat Strabismus Phase 2/Phase 3